KARUNA THERAPEUTICS INC shareholders Q2 2023

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.

KARUNA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$169,578,43555.90%
Nan Fung Group Holdings Ltd 225,688$48,940,44331.28%
Sofinnova Investments, Inc. 1,381,149$299,502,16119.62%
Paradigm Biocapital Advisors LP 283,605$61,499,7444.75%
First Light Asset Management, LLC 208,746$45,266,5703.55%
Avidity Partners Management LP 442,200$95,891,0703.35%
CATALYST PRIVATE WEALTH, LLC 21,837$4,735,3532.97%
Rock Springs Capital Management LP 493,527$107,021,3302.55%
Boxer Capital, LLC 250,000$54,2132.51%
DAFNA Capital Management LLC 42,173$9,145,2152.50%
GENERAL ATLANTIC, L.P. 726,958$157,640,8422.48%
UNC Management Company, Inc. 12,061$2,6152.36%
MPM BioImpact LLC 53,399$11,579,5732.33%
Nicholas Investment Partners, LP 155,930$33,813,4202.31%
Patient Capital Management, LLC 176,826$38,344,8182.13%
Parkman Healthcare Partners LLC 49,233$10,676,1761.85%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 25,700$5,566,6201.70%
Clarius Group, LLC 99,221$21,516,0741.66%
Atika Capital Management LLC 65,000$14,095,2501.41%
Eventide Asset Management 339,968$73,722,0611.25%
External links

This page lists KARUNA THERAPEUTICS INC's shareholders in Q2 2023. To view KARUNA THERAPEUTICS INC's shareholder history, click here.